Oral candidiasis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 38: Line 38:
==Natrual History, Comoplications, Prognosis==
==Natrual History, Comoplications, Prognosis==
   
   
There are no sequela with appropriate antifungal therapy. Mortality rate is almost 50% with bloodstream and disseminated infection.
There are no sequela with appropriate antifungal therapy. In contrast, among immunocompromised patients with disseminated infections, the mortality rate is almost 50%.


==Risk Factors==
==Risk Factors==

Revision as of 13:18, 2 September 2012

For patient information click here

Oral candidiasis
Oral thrush
ICD-10 B37.0
ICD-9 112.0
DiseasesDB 29743
MedlinePlus 000966

WikiDoc Resources for Oral candidiasis

Articles

Most recent articles on Oral candidiasis

Most cited articles on Oral candidiasis

Review articles on Oral candidiasis

Articles on Oral candidiasis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Oral candidiasis

Images of Oral candidiasis

Photos of Oral candidiasis

Podcasts & MP3s on Oral candidiasis

Videos on Oral candidiasis

Evidence Based Medicine

Cochrane Collaboration on Oral candidiasis

Bandolier on Oral candidiasis

TRIP on Oral candidiasis

Clinical Trials

Ongoing Trials on Oral candidiasis at Clinical Trials.gov

Trial results on Oral candidiasis

Clinical Trials on Oral candidiasis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Oral candidiasis

NICE Guidance on Oral candidiasis

NHS PRODIGY Guidance

FDA on Oral candidiasis

CDC on Oral candidiasis

Books

Books on Oral candidiasis

News

Oral candidiasis in the news

Be alerted to news on Oral candidiasis

News trends on Oral candidiasis

Commentary

Blogs on Oral candidiasis

Definitions

Definitions of Oral candidiasis

Patient Resources / Community

Patient resources on Oral candidiasis

Discussion groups on Oral candidiasis

Patient Handouts on Oral candidiasis

Directions to Hospitals Treating Oral candidiasis

Risk calculators and risk factors for Oral candidiasis

Healthcare Provider Resources

Symptoms of Oral candidiasis

Causes & Risk Factors for Oral candidiasis

Diagnostic studies for Oral candidiasis

Treatment of Oral candidiasis

Continuing Medical Education (CME)

CME Programs on Oral candidiasis

International

Oral candidiasis en Espanol

Oral candidiasis en Francais

Business

Oral candidiasis in the Marketplace

Patents on Oral candidiasis

Experimental / Informatics

List of terms related to Oral candidiasis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and related key words: OPC, thrush, oral thrush, candidiasis of the mouth and throat, candidosis, oral moniliasis

Overview

Oral candidiasis, is an infection of yeast fungus, Candida albicans, (or, less commonly, Candida glabrata or Candida tropicalis) in the mucous membranes of the mouth.

Pathophysiology

Candida albicans and C. glabrata. Less commonly, C.tropicalis, C. parapsilosis, and C. krusei. Rarely, other Candida species. Most cases of OPC are caused by the person’s own Candida organisms which normally live in the mouth or digestive tract. A person has symptoms when overgrowth of Candida organisms occurs.

Most infections are endogenous in origin, but organisms can be transmitted on the hands of care givers.

Epidemiology and Demographics

  • Thrush is the fourth most common cause of nosocomial bloodstream infections.
  • The incidence is 8 cases per 100,000 in the general population.
  • Higher incidence among neonates and African-Americans.
  • OPC used to be a common opportunistic infection in HIV-infected persons (prior to the introduction of highly active antiretroviral therapy HAART).

Natrual History, Comoplications, Prognosis

There are no sequela with appropriate antifungal therapy. In contrast, among immunocompromised patients with disseminated infections, the mortality rate is almost 50%.

Risk Factors

Invasive disease occurs in critically ill patients in intensive-care units, in persons with severe granulocytopenia, and in hematopoietic stem cell and organ transplant recipients. OPC can be associated with HIV infection. VVC is often associated with pregnancy, diabetes mellitus, and antibiotic therapy.

Who is at special risk?

  • Newborn babies.
  • Denture users.
  • Poorly controlled diabetes.
  • As a side effect of medication, most commonly having taken antibiotics. Inhaled corticosteroids for treatment of lung conditions (e.g, Asthma or COPD) may also result in oral candidiasis which may be reduced by regularly rinsing the mouth with water after taking the medication.
  • People with poor nutrition, specifically vitamin A, iron and folate deficiencies.
  • People with an immune deficiency (e.g. as a result of AIDS/HIV or chemotherapy treatment).
  • Women undergoing hormonal changes, like pregnancy or those on birth control pills
  • People who perform cunnilingus or fellatio on a sexual partner who has thrush.

Thrush and Breastfeeding

Because of the increased use of antibiotics in laboring women to reduce the transmission of Group B streptococcal infection to the infant, thrush has become more prevalent. Symptoms include:

  • An oral rash in the infant's mouth
  • A diaper rash that does not heal with conventional diaper rash treatments and ointments,
  • Burning, painful nipples for the breastfeeding mother.

The rash and pain experienced by the mother can range from severe to mild and may complicate breastfeeding. Because thrush is assumed to be benign, it may be difficult to obtain treatment for an outbreak in the diaper area of an infant or mother's nipples. Over the counter yeast infection cream, that comes in the 7-day package, can be applied to the skin with good results within 24 - 48 hours. It should be washed off nipples before breastfeeding.

Diagnosis

Symptoms

Adults may experience discomfort or burning in the mouth. Symptoms of candidiasis in the esophagus may include pain and dysphagia (difficult swallowing).

In babies the condition is termed thrush and is usually painless and causes no discomfort.

Physical Examination

Oral infections of candidia usually appear as thick white or cream-colour deposits. Underlying the deposits the mucosa of the mouth may appear inflamed (red and possibly slightly raised). Oral lesions are painless, white patches in the mouth.

Laboratory Studies

Agar plate culture of Candida albicans

Treatment

Any underlying cause, such as poor glucose control in diabetics, should be addressed. Oral candidiasis can be treated with topical anti-fungal drugs, such as nystatin (mycostatin), miconazole or amphotericin B. Patients who are immunocompromised, either with HIV/AIDS or as a result of chemotherapy, may require systemic treatment with oral or intravenous administered anti-fungals.

For adults, mild cases can be first treated by drinking acidic substances, such as orange juice, to make a harsher environment for the yeast and eating yogurt to replenish bacterial count that controls the yeast. If home treatment is not effective a physician may need to be consulted.

Prevention

Nosocomial disease surveillance is conducted by NNIS in selected hospitals. Active population-based surveillance for candidemia is being conducted in selected U.S. sites.

References

See Also

Template:Mycoses


da:Trøske (infektion) it:Mughetto (malattia)


Template:WikiDoc Sources